Prescription of statins: cost implications of evidence-based treatment applied to a health authority population-Reference-Cited by-同舟云学术

Prescription of statins: cost implications of evidence-based treatment applied to a health authority population

Published:1997-10 Issue:5-6 Volume:22 Page:379-389
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:

Author:

Bradshaw N.,Walker R.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.1997.tb00021.x/fullpdf

Reference35 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group;Lancet,1994

2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia;Shepherd;New England Journal of Medicine,1995

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;New England Journal of Medicine,1996

4. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary prevention through Intervention to Reduce Events). Principal results;ASPIRE Steering Group;Heart,1996

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternate-day Dosing with Statins;The American Journal of Medicine;2013-02

2. How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England;International Journal for Equity in Health;2007-03-27

3. ¿Qué estatina es más eficiente? Conceptos y aplicaciones en evaluación económica;Atención Primaria;2000